Lucira's at Home Molecular Tests Can Detect Omicron (B.1.1.529) SARS CoV-2 Variant of Concern
Lucira Health, Inc. (LHDX)
Company Research
Source: GlobeNewswire
Lucira assessment confirms COVID-19 Check-It (OTC) and All-In-One (Rx) molecular self-test kits' ability to detect 100% of Omicron variant genome sequences analyzedLucira assays target viral sequence regions unaffected by the spike protein mutations found in Omicron, Delta and other Variants of ConcernLucira's tests are the only EUA Authorized, at home self-test kits that deliver PCR quality accuracy and early detectability in a single-use, all-in-one kit with results in 30 minutes or less EMERYVILLE, Calif., Nov. 29, 2021 (GLOBE NEWSWIRE) -- Lucira Health, Inc. ("Lucira Health," "Lucira" or the "Company") (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, announced that its Lucira Check-It (OTC) and All-In-One (Rx) Test Kits can detect Omicron (B.1.1.529), a SARS CoV-2 Variant of Concern. Lucira Health performs ongoing surveillance of emerging SARS-CoV-2 strains by assessing
Show less
Read more
Impact Snapshot
Event Time:
LHDX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LHDX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LHDX alerts
High impacting Lucira Health, Inc. news events
Weekly update
A roundup of the hottest topics